Elena Ter‐Ovanesyan

A Polymer-Based Antibody–Vinca Drug Conjugate Platform: Characterization and Preclinical Efficacy

Alexander V. Yurkovetskiy, Mao Yin, Natalya D. Bodyak et al. · Cancer Research · 2015 · 100 citations

Pharmacy, Oncology, Pharmacology +17

Dolaflexin: A Novel Antibody–Drug Conjugate Platform Featuring High Drug Loading and a Controlled Bystander Effect

Aleksandr V. Yurkovetskiy, Natalya D. Bodyak, Mao Yin et al. · Molecular Cancer Therapeutics · 2021 · 75 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

Discovery and Optimization of a STING Agonist Platform for Application in Antibody Drug Conjugates

Jeremy R. Duvall, Joshua D. Thomas, Raghida A. Bukhalid et al. · Journal of Medicinal Chemistry · 2023 · 52 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +17

The Dolaflexin-based Antibody–Drug Conjugate XMT-1536 Targets the Solid Tumor Lineage Antigen SLC34A2/NaPi2b

Natalya D. Bodyak, Rebecca Mosher, Aleksandr V. Yurkovetskiy et al. · Molecular Cancer Therapeutics · 2021 · 48 citations · Full text

Medicine, Oncology, Pharmacology +17

Discovery and Preclinical Characterization of XMT-1660, an Optimized B7-H4-Targeted Antibody–Drug Conjugate for the Treatment of Cancer

Dorin Toader, Shawn P. Fessler, Scott D. Collins et al. · Molecular Cancer Therapeutics · 2023 · 39 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +17